Early breast cancer detection system being tested at major medical facility
Stony Brook, NY (PRWEB) July 13, 2005 -- Infrared Sciences Corporation (ISC) announced today that they have commenced a Clinical Study with the New York Presbyterian Hospital-Weill Medical College of Cornell University in New York City. The protocol will focus on determining the adjunctive effectiveness of the Infrared Sciences Sentinel BreastScan imaging system for early breast cancer detection. Study patients will have been scheduled for a breast biopsy, either by mammography or ultrasound. The Study will correlate the outcomes of radiology, pathology, and the Sentinel BreastScan.
We are pleased and excited to commence this study with Cornell, and we believe that the information obtained from the Sentinel system will prove it to be a highly effective adjunctive tool in the war against breast cancer" explained ISC Vice President, Matthew Campisi. The Sentinel system provides a new physiological dimension to breast health information that is not available from any other fully non-invasive testing method."
Sentinel BreastScan is a painless, touchless, non-invasive procedure offered to women of any age. The technology is based on advanced digital infrared imaging that is combined with sophisticated software employing artificial intelligence techniques. Immediately following the 4-minute test, it provides the doctor with a fully-interpreted, objective report. It is the only system like it in the world.
Sentinel BreastScan is intended to be an adjunctive procedure and does not replace mammography or ultrasound, or stand alone as a single test that can determine overall breast health.
For more information contact Infrared Sciences Corporation., at 213 Hallock Road, Suite 5, Stony Brook, New York, 11790. TEL: 631 240-9106, FAX: 631 240-9108, info@infraredsciences.com, or visit www.infraredsciences.com.
###
|
